What type of study is this?

September 10, 2025Frontiers in GeneticsOpen Access

Identification of epithelial-mesenchymal transition prognostic signature associated with prognosis, tumor microenvironment, and therapeutic effect in prostate cancer

View Full Paper

Ask AI

Bookmark

High-risk patients showed significantly lower survival rates, reflecting the prognostic value of the EPS risk score.
The EPS risk score, based on four key genes, serves as an independent prognostic factor in prostate cancer outcomes.
Clinical validation confirmed overexpression of key genes related to the EPS signature in prostate cancer tissues.
The high-risk group correlated with lower immune cell infiltration and poorer responses to therapies, emphasizing treatment implications.

No takes yet. Share an insight, caveat, or question.

Analysis reveals a prognostic signature in prostate cancer, suggesting ties to the tumor microenvironment and treatment response.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark